Related by context. Frequent words. (Click for all words.) 62 median PFS 61 free survival PFS 60 plus prednisone 60 plus dexamethasone 58 Secondary endpoints include 58 virologic response 58 virologic failure 57 neoadjuvant 57 HSCT 57 tanespimycin 57 evaluable 57 plus gemcitabine 57 nab paclitaxel 57 abiraterone acetate 57 glufosfamide 57 chemoradiotherapy 56 Secondary endpoints included 56 tumor resection 56 patients evaluable 56 Cloretazine R VNP#M 56 decitabine 56 evaluable patients 56 metastatic renal cell carcinoma 56 relapsed refractory multiple myeloma 56 sustained virologic response 56 QTc 55 dose cohorts 55 achieved statistical significance 55 Amrubicin 55 FOLFIRI 55 mg BID 55 axitinib 55 sapacitabine 55 metastatic hormone refractory 55 temsirolimus 55 GVAX 55 neoadjuvant therapy 55 Median survival 55 Torisel 55 neoadjuvant chemotherapy 55 RECIST criteria 54 imetelstat 54 SABCS 54 RRMS patients 54 androgen deprivation 54 cytogenetic response 54 coronary revascularization 54 azacitidine 54 dacarbazine 54 systemic embolism 54 Pharmacokinetic 54 TORISEL 54 engraftment 54 adalimumab 54 noninferiority 54 mg kg dose 54 secondary efficacy endpoints 54 AZOR 54 HER2 positive metastatic breast 54 Secondary endpoints 54 prespecified 54 disease progression 54 mg QD 54 fibrinolysis 53 monotherapy 53 placebo controlled clinical 53 topotecan 53 pertuzumab 53 virologic 53 unblinding 53 relapsed refractory 53 Fludara 53 mycophenolate mofetil 53 dose escalation 53 Jevtana 53 IPX# 53 dipyridamole 53 platelet inhibition 53 TELCYTA 53 gemcitabine 53 nonresponders 53 XGEVA 53 ponatinib 53 pazopanib 53 adjuvant therapy 53 diagnosed multiple myeloma 52 PROMACTA 52 sensitivity specificity 52 therapeutic regimens 52 dose regimens 52 dosing regimens 52 TACE 52 BROVANA 52 GvHD 52 sunitinib 52 gout flares 52 bosentan 52 adecatumumab 52 PRECiSE 52 pharmacodynamic effects 52 distant metastasis